id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1998-D-0025-0001,FDA,FDA-1998-D-0025,Draft Guidance an Current Good Manufacturing Practice for Positron Emission Tomography Drug Products; Availability [NAD2],Notice,NAD-Notice of Availability of Data,2005-09-20T04:00:00Z,2005,9,2005-09-15T04:00:00Z,2005-12-20T04:59:59Z,2009-05-04T06:59:04Z,,0,0,090000648056458e
FDA-1998-D-0025-0002,FDA,FDA-1998-D-0025,Guidance PET Drug Products – Current Good Manufacturing Practice (CGMP) - Draft Guidance,Supporting & Related Material,GDL-Guidance,2005-09-20T04:00:00Z,2005,9,,,2009-05-04T07:25:51Z,,0,0,0900006480564784
FDA-1998-D-0025-0003,FDA,FDA-1998-D-0025,Guidance PET Drug Products – Current Good Manufacturing Practice (CGMP) - Draft Guidance,Other,GDL-Guidance (Supporting and Related Materials),2005-09-20T04:00:00Z,2005,9,,,2009-05-04T07:23:27Z,,0,0,0900006480564787